Examination of Glutamate and mGluR5 in Psychiatric Disorders
Sponsor: VA Office of Research and Development
This NA trial investigates Bipolar Disorder and Major Depressive Disorder and is currently completed. VA Office of Research and Development leads this study, which shows 15 recorded versions since 2012 — indicating substantial longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
15 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
Nov 2022 — Dec 2023 [monthly]
Recruiting NA
-
May 2022 — Nov 2022 [monthly]
Recruiting NA
-
Dec 2021 — May 2022 [monthly]
Recruiting NA
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Mar 2020 [monthly]
Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Jan 2018 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jan 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .